Investors Are Watching: Cross Country Healthcare (NASDAQ:CCRN), Morgan Stanley (NYSE:MS), Bank of the Ozarks (NASDAQ:OZRK), MELA Sciences (NASDAQ:MELA), Concord Medical Services (NYSE:CCM)

Cross Country Healthcare, Inc. (NASDAQ:CCRN) on Aug 05, announced financial results for the second quarter ended June 30, 2015. Revenue was $192.6 million, up 57% year-over-year and 4% on a pro forma basis. Adjusted EBITDA was $8.2 million or 4.2% of revenue versus $3.3 million or 2.7% of revenue in the prior year. Reported diluted earnings per share (EPS) was $0.08; Adjusted EPS was $0.10. Cross Country Healthcare, Inc. (NASDAQ:CCRN) belongs to Services sector. Its net profit margin is -4.10% and weekly performance is 15.82%. On last trading day company shares ended up $13.98. Cross Country Healthcare, Inc. (NASDAQ:CCRN) distance from 50-day simple moving average (SMA50) is 14.56%.

Morgan Stanley (NYSE:MS) Real Estate Investing (MSREI) on Aug 05, announced that it has raised aggregate commitments of approximately $1.7 billion for North Haven Real Estate Fund VIII Global (G8) and related co-investment vehicles. Morgan Stanley (NYSE:MS) shares fell -0.90% in last trading session and ended the day at $38.58. MS Gross Margin is 87.10% and its return on assets is 0.50%. Morgan Stanley (NYSE:MS) quarterly performance is 2.21%.

Bank of the Ozarks, Inc. (NASDAQ:OZRK) announced on Aug 05, the completion of its acquisition of Bank of the Carolinas Corporation (“BCAR”) effective August 5, 2015 pursuant to a previously announced definitive agreement and plan of merger and reorganization between Bank of the Ozarks, Inc. (“Company”) and BCAR. This is the Company’s thirteenth acquisition since March 2010. On 07 August, Bank of the Ozarks, Inc. (NASDAQ:OZRK) shares advanced 0.25% and was closed at $44.43. OZRK EPS growth in last 5 year was 23.00%. Bank of the Ozarks, Inc. (NASDAQ:OZRK) year to date (YTD) performance is 18.39%.

MELA Sciences, Inc. (NASDAQ:MELA) ended the last trading day at $1.11. Company weekly volatility is calculated as 6.04% and price to cash ratio as 1.10. MELA Sciences, Inc. (NASDAQ:MELA) showed a weekly performance of -5.93%.

On Aug. 4, Concord Medical Services Holdings Limited (NYSE:CCM) announced it will release its financial results for the second quarter of 2015 after the market closes on August 17, 2015. Concord Medical Services Holdings Limited (NYSE:CCM) shares fell -7.39% in last trading session and ended the day at $4.89. CCM Gross Margin is 53.40% and its return on assets is 5.50%. Concord Medical Services Holdings Limited (NYSE:CCM) quarterly performance is -29.34%.

Leave a Reply

Your email address will not be published. Required fields are marked *